APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pruritus Therapeutics

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

In this report, we study the drugs for pruritus.

Selected research

Market Outlook & Growth Opportunities

Global Pruritus Therapeutics Market Outlook and Growth Opportunities 2026

Report ID 17389535042 January 2026190 pages

Choose your research edition.

Industry ResearchPruritus Therapeutics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pruritus Therapeutics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pruritus Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pruritus Therapeutics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pruritus Therapeutics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.

In this report, we study the drugs for pruritus.

Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.

Read the full market overview

North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.

This report provides an overview of the global Pruritus Therapeutics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pruritus Therapeutics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pruritus Therapeutics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pruritus Therapeutics market.

Pruritus Therapeutics Segment by Company

J&J

Abbott

Amgen

LEO Pharma

Novartis

Bayer

Pfizer

UCB Pharma

GlaxoSmithKline

Galderma

Huapont

Pruritus Therapeutics Segment by Type

Antihistamines

Corticosteroids

Calcineurin Inhibitors

Others

Pruritus Therapeutics Segment by Application

External Use

Oral

Injection

Pruritus Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pruritus Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pruritus Therapeutics key companies, revenue, market share, and recent developments.

3. To split the Pruritus Therapeutics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pruritus Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pruritus Therapeutics significant trends, drivers, influence factors in global and regions.

6. To analyze Pruritus Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pruritus Therapeutics industry.

Chapter 3: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pruritus Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pruritus Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pruritus Therapeutics Industry Trends Table 2. Pruritus Therapeutics Industry Drivers Table 3. Pruritus Therapeutics Industry Opportunities and Challenges Table 4. Pruritus Therapeutics Industry Restraints Table 5. Global Pruritus Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pruritus Therapeutics Revenue Share by Company (2021-2026) Table 7. Global Pruritus Therapeutics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pruritus Therapeutics Key Company Manufacturing Base & Headquarters Table 9. Global Pruritus Therapeutics Company, Product Type & Application Table 10. Global Pruritus Therapeutics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pruritus Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Antihistamines Table 15. Significant Companies of Corticosteroids Table 16. Significant Companies of Calcineurin Inhibitors Table 17. Significant Companies of Others Table 18. Global Pruritus Therapeutics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pruritus Therapeutics Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pruritus Therapeutics Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pruritus Therapeutics Sales Value Share by Type (2021-2026) Table 22. Global Pruritus Therapeutics Sales Value Share by Type (2027-2032) Table 23. Significant Companies of External Use Table 24. Significant Companies of Oral Table 25. Significant Companies of Injection Table 26. Global Pruritus Therapeutics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pruritus Therapeutics Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pruritus Therapeutics Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pruritus Therapeutics Sales Value Share by Application (2021-2026) Table 30. Global Pruritus Therapeutics Sales Value Share by Application (2027-2032) Table 31. Global Pruritus Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pruritus Therapeutics Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pruritus Therapeutics Sales Value Share by Region (2021-2026) Table 34. Global Pruritus Therapeutics Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pruritus Therapeutics Sales Value Share by Region (2027-2032) Table 36. Global Pruritus Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pruritus Therapeutics Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pruritus Therapeutics Sales Value Market Share by Country (2021-2026) Table 39. Global Pruritus Therapeutics Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pruritus Therapeutics Sales Value Market Share by Country (2027-2032) Table 41. J&J Company Information Table 42. J&J Business Overview Table 43. J&J Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. J&J Pruritus Therapeutics Product Portfolio Table 45. J&J Recent Development Table 46. Abbott Company Information Table 47. Abbott Business Overview Table 48. Abbott Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Abbott Pruritus Therapeutics Product Portfolio Table 50. Abbott Recent Development Table 51. Amgen Company Information Table 52. Amgen Business Overview Table 53. Amgen Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Amgen Pruritus Therapeutics Product Portfolio Table 55. Amgen Recent Development Table 56. LEO Pharma Company Information Table 57. LEO Pharma Business Overview Table 58. LEO Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. LEO Pharma Pruritus Therapeutics Product Portfolio Table 60. LEO Pharma Recent Development Table 61. Novartis Company Information Table 62. Novartis Business Overview Table 63. Novartis Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Novartis Pruritus Therapeutics Product Portfolio Table 65. Novartis Recent Development Table 66. Bayer Company Information Table 67. Bayer Business Overview Table 68. Bayer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bayer Pruritus Therapeutics Product Portfolio Table 70. Bayer Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Pruritus Therapeutics Product Portfolio Table 75. Pfizer Recent Development Table 76. UCB Pharma Company Information Table 77. UCB Pharma Business Overview Table 78. UCB Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. UCB Pharma Pruritus Therapeutics Product Portfolio Table 80. UCB Pharma Recent Development Table 81. GlaxoSmithKline Company Information Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline Pruritus Therapeutics Product Portfolio Table 85. GlaxoSmithKline Recent Development Table 86. Galderma Company Information Table 87. Galderma Business Overview Table 88. Galderma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Galderma Pruritus Therapeutics Product Portfolio Table 90. Galderma Recent Development Table 91. Huapont Company Information Table 92. Huapont Business Overview Table 93. Huapont Pruritus Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Huapont Pruritus Therapeutics Product Portfolio Table 95. Huapont Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Pruritus Therapeutics Product Image Figure 2. Global Pruritus Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pruritus Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Pruritus Therapeutics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Antihistamines Image Figure 8. Corticosteroids Image Figure 9. Calcineurin Inhibitors Image Figure 10. Others Image Figure 11. Global Pruritus Therapeutics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pruritus Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pruritus Therapeutics Sales Value Share by Type (2021-2032) Figure 14. External Use Image Figure 15. Oral Image Figure 16. Injection Image Figure 17. Global Pruritus Therapeutics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pruritus Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pruritus Therapeutics Sales Value Share by Application (2021-2032) Figure 20. Global Pruritus Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pruritus Therapeutics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pruritus Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pruritus Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pruritus Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pruritus Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pruritus Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pruritus Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pruritus Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pruritus Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pruritus Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pruritus Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pruritus Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Antihistamines
  • Corticosteroids
  • Calcineurin Inhibitors
  • Others
Applications
  • External Use
  • Oral
  • Injection
Companies covered
  • J&J
  • Abbott
  • Amgen
  • LEO Pharma
  • Novartis
  • Bayer
  • Pfizer
  • UCB Pharma
  • GlaxoSmithKline
  • Galderma
  • Huapont

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pruritus Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pruritus Therapeutics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pruritus Therapeutics Market Dynamics
  1. 2.1 Pruritus Therapeutics Industry Trends
  2. 2.2 Pruritus Therapeutics Industry Drivers
  3. 2.3 Pruritus Therapeutics Industry Opportunities and Challenges
  4. 2.4 Pruritus Therapeutics Industry Restraints
3 Pruritus Therapeutics Market by Company
  1. 3.1 Global Pruritus Therapeutics Company Revenue Ranking in 2025
  2. 3.2 Global Pruritus Therapeutics Revenue by Company (2021-2026)
  3. 3.3 Global Pruritus Therapeutics Company Ranking (2024-2026)
  4. 3.4 Global Pruritus Therapeutics Company Manufacturing Base and Headquarters
  5. 3.5 Global Pruritus Therapeutics Company Product Type and Application
  6. 3.6 Global Pruritus Therapeutics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pruritus Therapeutics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pruritus Therapeutics Market by Type
  1. 4.1 Pruritus Therapeutics Type Introduction
  2. 4.1.1 Antihistamines
  3. 4.1.2 Corticosteroids
  4. 4.1.3 Calcineurin Inhibitors
  5. 4.1.4 Others
  6. 4.2 Global Pruritus Therapeutics Sales Value by Type
  7. 4.2.1 Global Pruritus Therapeutics Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pruritus Therapeutics Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pruritus Therapeutics Sales Value Share by Type (2021-2032)
5 Pruritus Therapeutics Market by Application
  1. 5.1 Pruritus Therapeutics Application Introduction
  2. 5.1.1 External Use
  3. 5.1.2 Oral
  4. 5.1.3 Injection
  5. 5.2 Global Pruritus Therapeutics Sales Value by Application
  6. 5.2.1 Global Pruritus Therapeutics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pruritus Therapeutics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pruritus Therapeutics Sales Value Share by Application (2021-2032)
6 Pruritus Therapeutics Regional Value Analysis
  1. 6.1 Global Pruritus Therapeutics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pruritus Therapeutics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pruritus Therapeutics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pruritus Therapeutics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pruritus Therapeutics Sales Value (2021-2032)
  7. 6.3.2 North America Pruritus Therapeutics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pruritus Therapeutics Sales Value (2021-2032)
  10. 6.4.2 Europe Pruritus Therapeutics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pruritus Therapeutics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pruritus Therapeutics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pruritus Therapeutics Sales Value (2021-2032)
  16. 6.6.2 South America Pruritus Therapeutics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pruritus Therapeutics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pruritus Therapeutics Sales Value Share by Country, 2025 VS 2032
7 Pruritus Therapeutics Country-level Value Analysis
  1. 7.1 Global Pruritus Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pruritus Therapeutics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pruritus Therapeutics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pruritus Therapeutics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pruritus Therapeutics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pruritus Therapeutics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pruritus Therapeutics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 J&J
  2. 8.1.1 J&J Company Information
  3. 8.1.2 J&J Business Overview
  4. 8.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 J&J Pruritus Therapeutics Product Portfolio
  6. 8.1.5 J&J Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Pruritus Therapeutics Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Pruritus Therapeutics Product Portfolio
  18. 8.3.5 Amgen Recent Developments
  19. 8.4 LEO Pharma
  20. 8.4.1 LEO Pharma Company Information
  21. 8.4.2 LEO Pharma Business Overview
  22. 8.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
  24. 8.4.5 LEO Pharma Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Pruritus Therapeutics Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Pruritus Therapeutics Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Pruritus Therapeutics Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 UCB Pharma
  44. 8.8.1 UCB Pharma Company Information
  45. 8.8.2 UCB Pharma Business Overview
  46. 8.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
  48. 8.8.5 UCB Pharma Recent Developments
  49. 8.9 GlaxoSmithKline
  50. 8.9.1 GlaxoSmithKline Company Information
  51. 8.9.2 GlaxoSmithKline Business Overview
  52. 8.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
  54. 8.9.5 GlaxoSmithKline Recent Developments
  55. 8.10 Galderma
  56. 8.10.1 Galderma Company Information
  57. 8.10.2 Galderma Business Overview
  58. 8.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Galderma Pruritus Therapeutics Product Portfolio
  60. 8.10.5 Galderma Recent Developments
  61. 8.11 Huapont
  62. 8.11.1 Huapont Company Information
  63. 8.11.2 Huapont Business Overview
  64. 8.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huapont Pruritus Therapeutics Product Portfolio
  66. 8.11.5 Huapont Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst